<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170131032338N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-01-29</date_registration>
      <primary_sponsor>Tehran University of medical sciences, Research and Technology Dept.</primary_sponsor>
      <public_title>Effect of High power Laser in Knee Osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the short-term Effects of Continues, Pulsed and Super pulsed High power Laser irradiation on Pain and Function in Patient with Knee Osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-01-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/25226</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients are simply randomized to three experimental groups (Pulsed and Super pulsed High power Laser ) through random number table; received a special code and are treated with own group treatment, Blinding description: treatments are done by the researcher and; evaluations are done by another evaluator; none of them doesn't understand about patients grouping. moreover, analysis of data is done by a statistician who doesn't know about grouping. Also, the patients don't know about their group and other groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee Osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: The first group: 5 treatment sessions with continuous high power laser according to the Knee-arthrosis protocol of the Lumix 3 ultra device produced by Fisioline, Italy on the 8 points of the knee joint during 10 minutes with the total energy dose of 251.2 J accompanied by 3 routine exercise for knee osteoarthritis include: 1- Quadriceps setting, 2- Straight Leg Raising (SLR) and 3- Hamstring muscle stretching exercises. Intervention 2: The second group: 5 treatment sessions with pulsed high power laser according to the Analgesic protocol of the Lumix 3 ultra device produced by Fisioline, Italy on the 8 points of the knee joint during 10 minutes with the total energy dose of 199 J accompanied by 3 routine exercise for knee osteoarthritis include: 1- Quadriceps setting, 2- Straight Leg Raising (SLR) and 3- Hamstring muscle stretching exercises. Intervention 3: The third group: 5 treatment sessions with super-pulsed high power laser according to the Knee-arthrosis protocol of the Lumix 3 ultra device produced by Fisioline, Italy on the 8 points of the knee joint during 10 minutes with the total energy dose of 565 J accompanied by 3 routine exercise for knee osteoarthritis include: 1- Quadriceps setting, 2- Straight Leg Raising (SLR) and 3- Hamstring muscle stretching exercises.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Rahimpour Nadia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 267, 8/1 Ave., 1 Ave., Jomhouri Blvd.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7144984765</zip>
        <telephone>+98 71 3228 6628</telephone>
        <email>rahimpourpt@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rahimpour Nadia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.267, 8/1 Ave., 1 Ave., Jomhouri Blvd.</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7144984765</zip>
        <telephone>+98 71 3228 6628</telephone>
        <email>n-rahimpour@student.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age ≥ 50
Osteoarthritic knee of grade 2-3 based on radiographic diagnosis in the Kellegren and Lawrence grading of osteoarthritis by orthopedist physician.
The minimum score of 25 on the  Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score
Knee pain ≥ 4 on the visual analog scale (VAS)</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of physiotherapy and/or intra-articular injections during last 6 months.
Any history of knee surgery
History of fracture in knee
History of tearing of tendons, ligaments and menisci in knee joint
Central or peripheral neuropathy
Romatoid Arthritis
Malignancy in knee joint
Psychologic problems
Metabolic disease such as Diabetes, Thyroid, and Kidney problems
Infective disease
Ankylosis
Sever Synovitis
Sever valgus or Varus deformity
Incomplete treatment for any reasons
Osteoarthritic knee of grade 1,4 based on radiographic diagnosis in the Kellegren and Lawrence grading of osteoarthritis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Gonarthrosis [arthrosis of knee]</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first group: 5 treatment sessions with continuous high power laser according to the Knee-arthrosis protocol of the Lumix 3 ultra device produced by Fisioline, Italy on the 8 points of the knee joint during 10 minutes with the total energy dose of 251.2 J accompanied by 3 routine exercise for knee osteoarthritis include: 1- Quadriceps setting, 2- Straight Leg Raising (SLR) and 3- Hamstring muscle stretching exercises.</i_keyword>
      <i_keyword>The second group: 5 treatment sessions with pulsed high power laser according to the Analgesic protocol of the Lumix 3 ultra device produced by Fisioline, Italy on the 8 points of the knee joint during 10 minutes with the total energy dose of 199 J accompanied by 3 routine exercise for knee osteoarthritis include: 1- Quadriceps setting, 2- Straight Leg Raising (SLR) and 3- Hamstring muscle stretching exercises.</i_keyword>
      <i_keyword>The third group: 5 treatment sessions with super-pulsed high power laser according to the Knee-arthrosis protocol of the Lumix 3 ultra device produced by Fisioline, Italy on the 8 points of the knee joint during 10 minutes with the total energy dose of 565 J accompanied by 3 routine exercise for knee osteoarthritis include: 1- Quadriceps setting, 2- Straight Leg Raising (SLR) and 3- Hamstring muscle stretching exercises.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain Score. Timepoint: Evaluating the pain score before the first session and immediately after the first and the fifth treatment sessions. Method of measurement: (Visual Analog Scale) VAS and  (MCQ) (Mc-gill Questionnaire).</prim_outcome>
      <prim_outcome>Knee Function Score. Timepoint: Evaluating the knee function score before the first and immediately after the fifth treatment sessions. Method of measurement: WOMAC Questionnaire.</prim_outcome>
      <prim_outcome>Edema of knee joint, 10 cm above and 10 cm belong that. Timepoint: Evaluating the knee joint edema before the first session and immediately after the first and the fifth treatment sessions. Method of measurement: Measuring tape.</prim_outcome>
      <prim_outcome>Active Knee Extension ROM. Timepoint: Evaluating Active Knee Extension ROM before the first session and immediately after the first and the fifth treatment sessions. Method of measurement: Goniometer.</prim_outcome>
      <prim_outcome>Active Knee Flexion ROM. Timepoint: Evaluating Active Knee Flexion ROM before the first session and immediately after the first and the fifth treatment sessions. Method of measurement: Goniometer.</prim_outcome>
      <prim_outcome>Passive Knee Flexion ROM. Timepoint: Evaluating Passive Knee Flexion ROM before the first session and immediately after the first and the fifth treatment sessions. Method of measurement: Goniometer.</prim_outcome>
      <prim_outcome>Measuring Active Popliteal Angle. Timepoint: Measuring Active Popliteal Angle before the first session and immediately after the first and the fifth treatment sessions. Method of measurement: Goniometer.</prim_outcome>
      <prim_outcome>Measuring Passive Popliteal Angle. Timepoint: Measuring Passive Popliteal Angle before the first session and immediately after the first and the fifth treatment sessions. Method of measurement: Goniometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of medical sciences, Research and Technology Dept.</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-08-06</approval_date>
        <contact_name>Ethics Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Official Building, Medicine Faculty of Tehran University of Medical Sciences, Poorsina Ave., 16 Azar Ave., Keshavarz Blvd. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
